Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Magali Van den Bergh, Juliana Alvarez-Argote, Amruta H. Panwala & Constantin A. Dasanu. (2015) Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review. Current Medical Research and Opinion 31:10, pages 1861-1870.
Read now
Read now
Ming Valerie Lin, Wojciech Blonski & Gary R Lichtenstein. (2010) What is the optimal therapy for Crohn’s disease: step-up or top-down?. Expert Review of Gastroenterology & Hepatology 4:2, pages 167-180.
Read now
Read now
Jenny Vu Pozadzides & Barbara Pro. (2009) Hepatosplenic T-cell lymphoma and TNF-α inhibitors. Expert Review of Hematology 2:6, pages 611-614.
Read now
Read now
Renato Caviglia, Ivo Boškoski & Michele Cicala. (2008) Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues. Expert Opinion on Drug Safety 7:5, pages 617-632.
Read now
Read now
Gabor Veres, Robert N Baldassano & Petar Mamula. (2007) Infliximab therapy for pediatric Crohn's disease. Expert Opinion on Biological Therapy 7:12, pages 1869-1880.
Read now
Read now
Trevor A Winter, William J Sandborn, Willem JS de Villiers & Stefan Schreiber. (2007) Treatment of Crohn’s disease with certolizumab pegol. Expert Review of Clinical Immunology 3:5, pages 683-694.
Read now
Read now
Simon He, Andrew Roberts, David Ritchie & Andrew Grigg. (2007) Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma. Leukemia & Lymphoma 48:7, pages 1448-1450.
Read now
Read now
Amer Zeidan, Ronald Sham, Joel Shapiro, Anthony Baratta & Peter Kouides. (2007) Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy. Leukemia & Lymphoma 48:7, pages 1410-1413.
Read now
Read now
Articles from other publishers (59)
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano & Aileen Wee. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
842
946
.
Laura Gutiérrez-Ríos, Eva Vayreda, Margalida Calafat, Míriam Mañosa, Eugeni Dom�nech & Fiorella Cañete. (2023) HEPATOSPLENIC T-CELL LYMPHOMA AND INFLAMMATORY BOWEL DISEASE. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Daniella Klebaner, Divya Koura, Dimitrios Tzachanis, Edward D. Ball, Steven Horwitz & Aaron M. Goodman. (2020) Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 20:7, pages 431-437.e2.
Crossref
Crossref
Mridula Krishnan & Matthew Lunning. (2019) Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial?. Journal of Oncology Practice 15:6, pages 307-312.
Crossref
Crossref
Gabriel Mosquera-Klinger. (2019) Enfermedad de Crohn y linfoma primario de intestino delgado: reporte de caso. Revista Colombiana de Gastroenterología 34:1, pages 85.
Crossref
Crossref
Akira Satou, Toyonori Tsuzuki & Shigeo Nakamura. (2019) Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype. Journal of Clinical and Experimental Hematopathology 59:2, pages 56-63.
Crossref
Crossref
Philip H. Brandt, Leena T. Rahmat & Syed S. Ali. (2018) A rare case of hepatosplenic gamma‐delta T‐cell lymphoma and secondary hemophagocytic lymphohistiocytosis. Clinical Case Reports 7:1, pages 164-169.
Crossref
Crossref
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano & Aileen Wee. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
780
879
.
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa & Angelo Viscido. (2017) Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease 49:4, pages 338-358.
Crossref
Crossref
Mariko Yabe, L. Jeffrey Medeiros, Yahya Daneshbod, Masoud Davanlou, Carlos E. Bueso-Ramos, Elisa J. Moran, Ken H. Young & Roberto N. Miranda. (2017) Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor–α inhibitor therapy and literature review. Annals of Diagnostic Pathology 26, pages 16-22.
Crossref
Crossref
Maartje M van de Meeberg, Lauranne A A P Derikx, Harm A M Sinnige, Peet Nooijen, D Lucette Schipper & Loes H C Nissen. (2016) Hepatosplenic T-cell lymphoma in a 47-year-old Crohn’s disease patient on thiopurine monotherapy. World Journal of Gastroenterology 22:47, pages 10465.
Crossref
Crossref
A. Dohan, S.A. Faraoun, M. Barral, Y. Guerrache, M. Boudiaf, X. Dray, C. Hoeffel, M. Allez, O. Farges, L. Beaugerie, T. Aparicio, P. Marteau, E.K. Fishman, O. Lucidarme, C. Eveno, M. Pocard, R. Dautry & P. Soyer. (2015) Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. Diagnostic and Interventional Imaging 96:9, pages 871-883.
Crossref
Crossref
Anna Komitopoulou. (2015) Hepatosplenic T Cell Lymphoma in a Patient Treated with Infliximab for Crohn’s Disease not Responding to Conventional Therapies. Hematology & Transfusion International Journal 1:1.
Crossref
Crossref
Saranya A Selvaraj, Elizabeth Chairez, Lisa M Wilson, Mark Lazarev, Eric B Bass & Susan Hutfless. (2013) Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma. Systematic Reviews 2:1.
Crossref
Crossref
Koppany Visnyei, Michael L. Grossbard & Ilan Shapira. (2013) Hepatosplenic γδ T-cell Lymphoma: An Overview. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 360-369.
Crossref
Crossref
Ioannis E KoutroubakisAnna BuchnerWojciech BlonskiGary R Lichtenstein. 2013. Advances in the Management of Inflammatory Bowel Disease. Advances in the Management of Inflammatory Bowel Disease
104
122
.
Sebastian Strobel & Maria T. Abreu. (2012) Biologic Therapy in Inflammatory Bowel Disease—A Gastrointestinal Perspective. Seminars in Colon and Rectal Surgery 23:2, pages 81-88.
Crossref
Crossref
Livia Biancone, Sara Zuzzi, Micaela Ranieri, Carmelina Petruzziello, Emma Calabrese, Sara Onali, Marta Ascolani, Francesca Zorzi, Giovanna Condino, Simona Iacobelli & Francesco Pallone. (2012) Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study. Journal of Crohn's and Colitis 6:5, pages 578-587.
Crossref
Crossref
Zachary D. Goodman, Luigi M. Terracciano & Aileen Wee. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
761
851
.
Zeba N. Singh, Nirali M. Patel & Margaret L. Gulley. 2012. Pediatric Neoplasia. Pediatric Neoplasia
101
124
.
Lisa J. Herrinton, Liyan Liu, Oren Abramson & Elaine S. Jaffe. (2012) The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. Pharmacoepidemiology and Drug Safety 21:1, pages 49-52.
Crossref
Crossref
Anna M. Buchner, Wojciech Blonski & Gary R. Lichtenstein. (2011) Update on the Management of Crohn’s Disease. Current Gastroenterology Reports 13:5, pages 465-474.
Crossref
Crossref
O. H. Nielsen, J. B. Seidelin, L. K. Munck & G. Rogler. (2011) Use of biological molecules in the treatment of inflammatory bowel disease. Journal of Internal Medicine 270:1, pages 15-28.
Crossref
Crossref
Arthur F. Kavanaugh, Lloyd F. Mayer, John J. Cush & Stephen B. Hanauer. (2011) Shared Experiences and Best Practices in the Management of Rheumatoid Arthritis and Crohn's Disease. The American Journal of Medicine 124:4, pages e1-e18.
Crossref
Crossref
Jens Kelsen, Anders Dige, Heinrich Schwindt, Francesco D'Amore, Finn S. Pedersen, Jørgen Agnholt, Lisbet A. Christensen, Jens F. Dahlerup & Christian L. Hvas. (2011) Infliximab Induces Clonal Expansion of γδ-T Cells in Crohn's Disease: A Predictor of Lymphoma Risk?. PLoS ONE 6:3, pages e17890.
Crossref
Crossref
. 2011. British Association of Dermatologists' Management Guidelines. British Association of Dermatologists' Management Guidelines
205
317
.
G. Horneff, I. Foeldvari, K. Minden, D. Moebius & T. Hospach. (2010) Report on malignancies in the German juvenile idiopathic arthritis registry. Rheumatology 50:1, pages 230-236.
Crossref
Crossref
David S. Kotlyar, Mark T. Osterman, Robert H. Diamond, David Porter, Wojciech C. Blonski, Mariusz Wasik, Sami Sampat, Manuel Mendizabal, Ming V. Lin & Gary R. Lichtenstein. (2011) A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 9:1, pages 36-41.e1.
Crossref
Crossref
Anne Thai & Thomas Prindiville. (2010) Hepatosplenic T-cell lymphoma and inflammatory bowel disease. Journal of Crohn's and Colitis 4:5, pages 511-522.
Crossref
Crossref
Udayakumar Navaneethan & Bo Shen. (2010) Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflammatory Bowel Diseases 16:9, pages 1598-1619.
Crossref
Crossref
G. Horneff. (2010) Malignome und Tumor-Nekrose-Faktor-Inhibitoren bei der juvenilen idiopathischen ArthritisMalignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. Zeitschrift für Rheumatologie 69:6, pages 516-526.
Crossref
Crossref
G. Horneff, T. Hospach, G. Dannecker, D. Föll, J.P. Haas, H.J. Girschick, H.I. Huppertz, R. Keitzer, H.J. Laws, H. Michels, K. Minden & R. Trauzeddel. (2010) Aktualisierte Stellungnahme der GKJR zur Meldung der FDA über Fälle von Malignomen bei Anti-TNF-behandelten Patienten vom 04.08.2009Updated statement by the German Society for Pediatric and Adolescent Rheumatology (GKJR) on the FDA’s report regarding malignancies in anti-TNF-treated patients from Aug. 4, 2009. Zeitschrift für Rheumatologie 69:6, pages 561-567.
Crossref
Crossref
M. A. Smith, P. M. Irving, A. M. Marinaki & J. D. Sanderson. (2010) Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 32:2, pages 119-130.
Crossref
Crossref
Corey A. Siegel. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
678
692
.
Mark G. Ochenrider, David J. Patterson & David M. Aboulafia. (2010) Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review. Clinical Lymphoma Myeloma and Leukemia 10:2, pages 144-148.
Crossref
Crossref
G. Horneff, T. Hospach, G. Dannecker, D. Föll, J.P. Haas, H. Girschick, H.I. Huppertz, R. Keitzer, H.J. Laws, K. Minden, R. Trauzeddel & H. Michels. (2010) Therapie mit TNFα-InhibitorenTNFα-inhibitor therapy. Monatsschrift Kinderheilkunde 158:4, pages 372-377.
Crossref
Crossref
Meenakshi Bewtra & James D. Lewis. (2010) Safety Profile of IBD: Lymphoma Risks. Medical Clinics of North America 94:1, pages 93-113.
Crossref
Crossref
Meenakshi Bewtra & James D. Lewis. (2009) Safety Profile of IBD: Lymphoma Risks. Gastroenterology Clinics of North America 38:4, pages 669-689.
Crossref
Crossref
C.H. Smith, A.V. Anstey, J.N.W.N. Barker, A.D. Burden, R.J.G. Chalmers, D.A. Chandler, A.Y. Finlay, C.E.M. Griffiths, K. Jackson, N.J. McHugh, K.E. McKenna, N.J. Reynolds & A.D. Ormerod. (2009) British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology 161:5, pages 987-1019.
Crossref
Crossref
G.S. Falchook, F. Vega, N.H. Dang, F. Samaniego, M.A. Rodriguez, R.E. Champlin, C. Hosing, S. Verstovsek & B. Pro. (2009) Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Annals of Oncology 20:6, pages 1080-1085.
Crossref
Crossref
Marc Beyer, Matthias Steinhoff, Ioannis Anagnostopoulos, Chalid Assaf & Wolfram Sterry. (2009) Hepatosplenic T‐cell lymphomas and therapy with TNF‐α‐blocking biologics: a risk for psoriasis patients?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 7:3, pages 191-194.
Crossref
Crossref
Ann Corken Mackey, Lanh Green, Christopher Leptak & Mark Avigan. (2009) Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update. Journal of Pediatric Gastroenterology & Nutrition 48:3, pages 386-388.
Crossref
Crossref
Salvatore Cucchiara, Johanna C Escher, Hans Hildebrand, Jorge Amil-Dias, Laura Stronati & Frank M Ruemmele. (2009) Pediatric Inflammatory Bowel Diseases and the Risk of Lymphoma: Should We Revise Our Treatment Strategies?. Journal of Pediatric Gastroenterology & Nutrition 48:3, pages 257-267.
Crossref
Crossref
Gary R Lichtenstein, Stephen B Hanauer & William J Sandborn. (2009) Management of Crohn's Disease in Adults. The American Journal of Gastroenterology 104:2, pages 465-483.
Crossref
Crossref
A. LAU, N. CHANDE, T. PONICH & J. C. GREGOR. (2008) Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study. Alimentary Pharmacology & Therapeutics 28:5, pages 606-613.
Crossref
Crossref
Jeremy S. Abramson, Camille N. Kotton, Nahel Elias, Dushyant V. Sahani & Robert P. Hasserjian. (2008) Case 8-2008. New England Journal of Medicine 358:11, pages 1176-1187.
Crossref
Crossref
Sèverine Vermeire, Gert Van Assche & Paul Rutgeerts. 2008. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
387
401
.
Jennifer L. Jones & Edward V. LoftusJr.Jr.. (2007) Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?. Inflammatory Bowel Diseases 13:10, pages 1299-1307.
Crossref
Crossref
Pere Vilar, Javier Martín de Carpi, Claudia E. Acuña & Ma Luisa Masiques. (2007) Infliximab in paediatric inflammatory bowel disease. Journal of Crohn's and Colitis 1:1, pages 2-9.
Crossref
Crossref
Johanna C. Escher. (2007) Look before you leap. Inflammatory Bowel Diseases 13:9, pages 1176-1177.
Crossref
Crossref
Joel R. Rosh, Thomas Gross, Petar Mamula, Anne Griffiths & Jeffrey Hyams. (2007) Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohnʼs disease: A cautionary tale?. Inflammatory Bowel Diseases 13:8, pages 1024-1030.
Crossref
Crossref
Eve A. Roberts. 2009. Liver Disease in Children. Liver Disease in Children
478
512
.
Ann Corken Mackey, Lanh Green, Li-ching Liang, Patricia Dinndorf & Mark Avigan. (2007) Hepatosplenic T Cell Lymphoma Associated With Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 44:2, pages 265-267.
Crossref
Crossref
Gabor Veres, Robert N Baldassano & Petar Mamula. (2007) Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease. Drugs 67:12, pages 1703-1723.
Crossref
Crossref
Geoffrey C. Nguyen, Mary L. Harris & Themistocles Dassopoulos. (2006) Insights in immunomodulatory therapies for ulcerative colitis and Crohn’s disease. Current Gastroenterology Reports 8:6, pages 499-505.
Crossref
Crossref
S. Mittal, B. J. Milner, P. W. Johnston & D. J. Culligan. (2006) A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to Fludarabine and Alemtuzumab. European Journal of Haematology 76:6, pages 531-534.
Crossref
Crossref
Elaine S. Jaffe. (2006) Pathobiology of Peripheral T-cell Lymphomas. Hematology 2006:1, pages 317-322.
Crossref
Crossref
Evarist Feliu-Frasnedo. (2005) La sesión clinicocitológica: un rincón muy especial de reunión de la familia hematológica. Medicina Clínica 125:19, pages 740-744.
Crossref
Crossref
Meena Thayu, Jonathan E. Markowitz, Petar Mamula, Pierre A. Russo, William I. Muinos & Robert N. Baldassano. (2005) Hepatosplenic T-Cell Lymphoma in an Adolescent Patient after Immunomodulator and Biologic Therapy for Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 40:2, pages 220-222.
Crossref
Crossref